Fact sheet: Unicorn Outstanding BritishCos

Fund information

Fund name
Unicorn Outstanding British Companies B
Fund company manager
Unicorn Asset Management
Fund type
OEIC
Fund manager(s)
Chris Hutchinson
since 08/12/2006
Fund objective
The Unicorn Outstanding British Companies Fund aims to achieve the highest predictable annual compounding rate of return over the long-term, where long-term is defined as being not less than five years, by investing in a collection of outstanding British companies, either fully listed or quoted on the Alternative Investment Market, with the least amount of economic, as distinct, from market price risk. Outstanding companies are those whose economics and risks are well understood, whose revenues, earnings and cash flows are predictable to a high degree of certainty, which sell products and services into growing markets, which have market leadership positions and lasting competitive strength, which generate high average and incremental returns on invested capital, which convert a high proportion of their earnings into free, distributable cash, which can show a consistent track record of operating performance, which are run by decent, experienced individuals, who manage their businesses with the goal of maximising owner-value, which operate with low core debt, which are not predominantly acquisition-led, which produce clean, intelligible financial statements. Up to 25% of the fund will be invested in smaller faster growing companies with the remainder in more established businesses.
Benchmark
FTSE All Share
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

6.99 %

1 Year rank in sector

255/272

Sector

UT UK All Companies

Yield

1.4634

Fund size

£ 51.4 m

FE Risk score

63

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • UK
    88.14%
  • Money Market
    11.86%
  • Support Services
    14.24%
  • Pharmaceuticals
    13.13%
  • Money Market
    11.86%
  • Healthcare & Medical Products
    8.34%
  • Financial Services
    8.28%
  • UK Equities
    88.14%
  • Cash & Cash Equivalents
    11.86%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund3.42 %6.58 %6.99 %51.36 %77.1 %
Sector3.28 %6.99 %14.25 %38.35 %64.85 %
Rank within sector101 / 279167 / 277255 / 27247 / 25576 / 242
Quartile th2 nd3 rd4 th1 st2 nd

Calendar performance

YTD-20172016201520142013
Fund10.81 %4.16 %18.96 %-3.1 %27.73 %
Sector11.56 %11.16 %3.66 %0.59 %25.66 %
Rank within sector121 / 275229 / 26512 / 258227 / 252104 / 245
Quartile th2 nd4 th1 st4 th2 nd

Risk statistics

Alpha4.45
Beta0.87
Sharpe0.98
Volatility9.13
Tracking error4.97
Information ratio0.64
R-Squared0.72

Price movement

52 week high317.75
52 week low275.13
Current bid price0
Current offer price0
Current mid price315.29

Holdings by region

  • 88.14% UK
  • 11.86% Money Market

Holdings by sector

  • 14.24% Support Services
  • 13.13% Pharmaceuticals
  • 11.86% Money Market
  • 8.34% Healthcare & Medical Products
  • 8.28% Financial Services
  • 7.61% Electronic & Electrical Equipment
  • 6.94% Chemicals
  • 5.45% Retailers - General
  • 4.91% Software
  • 3.31% Industrials

Holdings by asset type

  • 88.14% UK Equities
  • 11.86% Cash & Cash Equivalents

Individual holdings

  • 4.14% RENISHAW PLC
  • 3.88% RWS HLDGS
  • 3.85% ABCAM
  • 3.63% DECHRA PHARMACEUTICALS
  • 3.62% VICTREX
  • 3.61% VP
  • 3.47% GOOCH & HOUSEGO PLC
  • 3.4% ADVANCED MEDICAL SOLUTIONS GROUP
  • 3.4% ANPARIO PLC
  • 3.31% JOHNSON MATTHEY